Viewing Study NCT04848467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
Study NCT ID: NCT04848467
Status: WITHDRAWN
Last Update Posted: 2021-08-11
First Post: 2021-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None SARS-CoV-2 Infection View
None Coronavirus Disease 2019 (COVID-19) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) View
None COVID-19 View
None mRNA Vaccine View
None SARS-CoV-2 mRNA Vaccine (CVnCoV) View
None Quadrivalent influenza vaccine (QIV) View